{
    "code": "01038765",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01038765",
    "time": "2020-01-31 04:01:01",
    "許可證字號": "衛署藥製字第038765號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/12\/31",
    "發證日期": "84\/04\/19",
    "許可證種類": "製　劑",
    "舊證字號": "12008296",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103876502",
    "中文品名": "瑠美阿託注射液",
    "英文品名": "LUMIATO INJECTION",
    "適應症": "嘔吐、胃腸痙攣、氣喘發作痙攣、鎮痙",
    "劑型": "270注射劑",
    "包裝": "1公撮安瓿 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 34第四級管制藥品",
        "申請商名稱": "6231147074  東洲化學製藥廠股份有限公司",
        "申請商地址": "新北市蘆洲區中山二路195巷12號1-2樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208000530",
            "成分名稱": "ATROPINE SULFATE",
            "含量描述": "",
            "含量": "0.2500000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2820000420",
            "成分名稱": "CAFFEINE SODIUM BENZOATE",
            "含量描述": "",
            "含量": "30.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2824401210",
            "成分名稱": "PHENOBARBITAL SODIUM",
            "含量描述": "",
            "含量": "60.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "6cm玻璃安瓿",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "010387650003-外觀瑠美阿託-104-12-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038765&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "010387650001仿單-瑠美阿託注射液-108-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038765&Seq=004&Type=9"
        },
        {
            "title": "010387650001-仿單瑠美阿託-104-12-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038765&Seq=003&Type=9"
        },
        {
            "title": "010387650002標籤-瑠美阿託注射液-108-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038765&Seq=002&Type=8"
        },
        {
            "title": "010387650004-外盒瑠美阿託-104-12-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038765&Seq=001&Type=8"
        }
    ]
}